Portfolio Growth Active Motif has expanded its tools and services through strategic acquisitions and partnerships, broadening its product portfolio with SwitchGear Genomics and AmaryllisNucleics and integrating RNA sequencing capabilities with existing epigenetics offerings. This creates cross sell opportunities for multi omics workflows among academic labs and pharma partners seeking turnkey solutions.

End to End The launch of an end to end Hi C service in collaboration with Arima Genomics positions Active Motif as a one stop provider for epigenetic assays and 3D genome analysis, enabling pharma and translational research teams to access integrated data and services in a single vendor.

Global Partnerships Strategic distribution and regional partnerships, including Proteintech in China and Asia Pacific expansion, create channels to reach academic and biotech customers faster, presenting opportunities for channel driven upsell of reagents, kits, and services.

Data Platform A combined wet lab toolkit with a bioinformatics platform enables selling not only products and services but also data analysis and interpretation capabilities for multiomics studies, helping customers extract actionable insights for drug discovery.

Scale Readiness A mid market scale business with demonstrated growth signals shows appetite for larger multi year service contracts, premium support, enterprise licensing, and expanded service offerings with pharma, biotech and academic customers.